Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Hemostemix Inc (HEM)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.0400 0.0000    0.00%
30/04 - Delayed Data. Currency in CAD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.0350 / 0.0400
  • Day's Range: 0.0400 - 0.0400
Type:  Equity
Market:  Canada
Hemostemix Inc 0.0400 0.0000 0.00%

HEM Financial Summary

 
A brief financial summary of Hemostemix Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Hemostemix Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was CAD 0.257243 million compared to CAD 0.810527 million a year ago. Basic loss per share from continuing operations was CAD 0.003 compared to CAD 0.011 a year ago. Diluted loss per share from continuing operations was CAD 0.003 compared to CAD 0.011 a year ago.For the nine months, net loss was CAD 1.82 million compared to CAD 3.89 million a year ago. Basic loss per share from continuing operations was CAD 0.024 compared to CAD 0.062 a year ago. Diluted loss per share from continuing operations was CAD 0.024 compared to CAD 0.062 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

HEM Income Statement

Gross margin TTM -
Operating margin TTM 0%
Net Profit margin TTM 0%
Return on Investment TTM 0%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue
Gross Profit
Operating Income -0.38 -0.388 -1.1
Net Income -0.257 -1.28

HEM Balance Sheet

Quick Ratio MRQ 0.14
Current Ratio MRQ 0.25
LT Debt to Equity MRQ 0%
Total Debt to Equity MRQ -62.61%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 0.314 0.701 0.501
Total Liabilities 7.55 7.48
Total Equity -6.85 -6.98

HEM Cash Flow Statement

Cash Flow/Share TTM -0.02
Revenue/Share TTM -
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -0.066 -0.711
Cash From Investing Activities
Cash From Financing Activities 0.018 0.289 0.848
Net Change in Cash 0.223 0.137
* In Millions of CAD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

HEM Comments

Write your thoughts about Hemostemix Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lucas zex
Lucas zex Oct 31, 2023 10:47
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The negative impact on the stock market stemming from $HEM's poor services has been a source of disappointment for investors who have suffered losses. I also suffered losses.
Reply
0 0
Report
William max
William max Oct 31, 2023 7:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Shareholders of $HEM face a challenging situation as the company's profitability remains elusive, casting shadows of uncertainty over the company's future.
Reply
0 0
Report
Markis jax
Markis jax Oct 30, 2023 14:37
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$HEM's stock continued to underperform, with a 15% decrease to $0.085 on the previous trading day, resulting in financial losses for investors.
Reply
0 0
Report
James Macho
James Macho Oct 30, 2023 8:43
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$HEM continues to struggle financially, with no signs of profitability in sight. Shareholders are left with uncertainty about the company's future.
Reply
0 0
Report
ranchhodd das
ranchhodd das May 08, 2023 14:04
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The technical analysis of the stock $HEM shows that it is trading at an affordable price, with more than 81 million outstanding shares. As a healthcare stock, it will be a good option for long-term investors .
Reply
0 0
Report
Jack Mallick
Jack Mallick May 05, 2023 9:44
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This stock has proven to be a trustworthy pick for investors seeking consistent, long-term gains. Its steadiness has made it an attractive option among investors, as seen by the high number of 65K shares traded yesterday.
Reply
0 0
Report
Braxton lee
Braxton lee May 04, 2023 10:33
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$HEM has consistently delivered a good return. The company has maintained financial stability and has the potential to continue bolstering its market share in the coming months.
Reply
0 0
Report
Jack Mallick
Jack Mallick May 01, 2023 10:41
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The company has a market capitalization of $12.97 million and has been gaining popularity among investors due to its low-cost offering and potential for future growth. HEM has a diversified portfolio of investments and a well-managed balance sheet, which gives investors confidence in the company's long-term stability and future prospects.
Reply
0 0
Report
ranchhodd das
ranchhodd das Apr 25, 2023 15:43
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hemostemix is looking to expand and has been conducting interviews for a new Executive VP of Business Development. The stock is trading at a pocket friendly price over TSX-V .
Reply
0 0
Report
ranchhodd das
ranchhodd das Apr 17, 2023 10:42
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The technical analysis of the stock $HEM shows that it is trading at an affordable price, with more than 81 million outstanding shares. As a healthcare stock, it looks quite profitable for long-term investors.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email